June 29, 2020
1 min read
Save

Top 5 psychiatry stories of June

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio Psychiatry has compiled a list of its top five viewed stories in June.

A study on electronic health record-related fatigue among physicians, data on a fatty acid diet intervention for mood stabilization among patients with bipolar disorder and poll results related to self-care practices during the COVID-19 pandemic were just some of the most-read stories on Healio Psychiatry for the month.

Which story resonated with you most? Leave a comment or write to us on Twitter @HealioPsych.

EHR-related fatigue may lead to inefficient use among physicians

Continuous EHR use was associated with fatigue among physicians, which may lead to inefficient and suboptimal EHR use, according to results of a study published in JAMA Network Open. Read more.

Fatty acid diet intervention may stabilize mood among patients with bipolar disorder

A nutrition intervention focused on fatty acids may stabilize mood, energy, irritability and pain among individuals with bipolar disorder, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting. Read more.

80% of Americans intend to regularly practice self-care after COVID-19 pandemic

Most U.S. adults reported intentions to become more mindful about engaging in regular self-care practices after the COVID-19 pandemic, according to survey results. Read more.

Safety of psilocybin lays groundwork for research in treatment-resistant depression

A psilocybin formulation was well-tolerated among healthy patients, which supports research into its use for treatment-resistant depression, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting. Read more.

Data outline real-world early use of esketamine nasal spray for treatment-resistant depression

Data presented at the American Society of Clinical Psychopharmacology Annual Meeting showed prescribing practices and outcomes related to esketamine nasal spray. Read more.